Atlas Trials

Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem Brain Tissue Tau Pathology in Individuals With HV and MCI or AD.

Clinical trial NCT07752784 · RECRUITING

Trial details

NCT number
NCT07752784
Sponsor
JYAMS PET Research & Development Limited
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2026-08-15
Primary completion
2027-04-30
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.